tirzepatide as compared with semaglutide for the treatment of obesity paper 'Tirzepatide the Obesity' directly compared the two best-known GLP-1 medicines used to treat in people without diabetes. The study found that while Tirzepatide vs. Semaglutide: Which GLP-1

Byetta and Bydureon are FDA-approved to treat type 2 diabetes

According to the FDA-approved prescribing information for Wegovy (semaglutide, current label on file with the FDA as of 2026) and Zepbound (tirzepatide, current label on file with the FDA as of 2026), both carry these warnings: A boxed warning - the FDA's most serious warning category - for thyroid C-cell tumors observed in rodent studies

Effect of probiotic (VSL# 3) and omega-3 on lipid profile, insulin sensitivity, inflammatory markers, and gut colonization in overweight adults: A randomized, controlled trial

There is no established link between retatrutide and serious long-term fatigue disorders, but all persistent or unexplained symptoms deserve thorough clinical evaluation

Currently, there is no cure, though some medications slow progression in select patients